Management and prognosis of pancreatic cancer over a 30-year period

被引:67
作者
David, M. [1 ,2 ,3 ]
Lepage, C. [1 ,2 ,3 ]
Jouve, J-L [1 ,2 ,3 ]
Jooste, V. [1 ,2 ,3 ]
Chauvenet, M. [1 ,2 ,3 ]
Faivre, J. [1 ,2 ,3 ]
Bouvier, A-M [1 ,2 ,3 ]
机构
[1] Registre Canc Digestifs, INSERM, U866, F-21079 Dijon, France
[2] Univ Bourgogne, F-21079 Dijon, France
[3] CHU, F-21079 Dijon, France
关键词
pancreatic cancer; cancer registry; management; stage at diagnosis; survival; SURVIVAL; POPULATION;
D O I
10.1038/sj.bjc.6605150
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The aim of this study was to report on changes in the diagnostic assessment, patterns of care and survival over time for pancreatic cancers. METHODS: A total of 2986 cases of pancreatic cancer from the Digestive Cancer Registry of Burgundy (France) over a 30-year period (1976-2005) were considered. Non-conditional logistic regressions were carried out to identify the factors associated with resection for cure and with the use of chemotherapy. A multivariate relative survival analysis was carried out. RESULTS: Diagnostic procedures have changed. Ultrasonography and computed tomography progressively have become the major diagnostic procedures. There was a slight improvement in stage: the proportion of stage I-II was 2.8% in the 1976-1980 period and 8.8% in the 2001-2005 period (P<0.001). There was a similar trend in the proportion of cases resected for cure, the corresponding percentages being 4.5 and 11.3%, respectively (P<0.001). The 5-year relative survival increased from 2.0 to 4.2% (P<0.001). In the multivariate relative survival analysis, the period remained a significant prognostic factor. Stage, sex, age and histology were independent prognostic factors. CONCLUSION: Over a 30-year period, there were minor changes in the stage at diagnosis, resection for cure and prognosis of pancreatic cancers, although there were improvements in the diagnostic modalities. Pancreatic cancer still represents a major challenge in oncology. British Journal of Cancer (2009) 101, 215-218. doi:10.1038/sj.bjc.6605150 www.bjcancer.com Published online 30 June 2009 (C) 2009 Cancer Research UK
引用
收藏
页码:215 / 218
页数:4
相关论文
共 9 条
[1]   National failure to operate on early stage pancreatic cancer [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Ko, Clifford Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Talamonti, Mark S. .
ANNALS OF SURGERY, 2007, 246 (02) :173-180
[2]   Prognostic factors for survival in pancreatic cancer: a population-based study [J].
Eloubeidi, Mohamad A. ;
Desmond, Renee A. ;
Wilcox, C. Mel ;
Wilson, Reda J. ;
Manchikalapati, Pavan ;
Fouad, Mona M. ;
Eltoum, Isam ;
Vickers, Selwyn M. .
AMERICAN JOURNAL OF SURGERY, 2006, 192 (03) :322-329
[3]   Differences in survival by histologic type of pancreatic cancer [J].
Fesinmeyer, MD ;
Austin, MA ;
Li, CI ;
De Roos, AJ ;
Bowen, DJ .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (07) :1766-1773
[4]   Incidence and management of malignant digestive endocrine tumours in a well defined French population [J].
Lepage, C ;
Bouvier, AM ;
Phelip, JM ;
Hatem, C ;
Vernet, C ;
Faivre, J .
GUT, 2004, 53 (04) :549-553
[5]   Survival from cancer of the pancreas in England and Wales up to 2001 [J].
Mitry, E. ;
Rachet, B. ;
Quinn, M. J. ;
Cooper, N. ;
Coleman, M. P. .
BRITISH JOURNAL OF CANCER, 2008, 99 (Suppl 1) :S21-S23
[6]  
RIES L, 2008, CANC SURVIVAL ADULTS, pCH7
[7]   EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary [J].
Sant, M. ;
Aareleid, T. ;
Berrino, F. ;
Lasota, M. Bielska ;
Carli, P. M. ;
Faivre, J. ;
Grosclaude, P. ;
Hedelin, G. ;
Matsuda, T. ;
Moller, H. ;
Moller, T. ;
Verdecchia, A. ;
Capocaccia, R. ;
Gatta, G. ;
Micheli, A. ;
Santaquilani, M. ;
Roazzi, P. ;
Lisi, D. .
ANNALS OF ONCOLOGY, 2003, 14 :V61-V118
[8]   Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer [J].
Stocken, DD ;
Büchler, MW ;
Dervenis, C ;
Bassi, C ;
Jeekel, H ;
Klinkenbijl, JHG ;
Bakkevold, KE ;
Takada, T ;
Amano, H ;
Neoptolemos, JP .
BRITISH JOURNAL OF CANCER, 2005, 92 (08) :1372-1381
[9]   Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses [J].
Sultana, A. ;
Smith, C. Tudur ;
Cunningham, D. ;
Starling, N. ;
Neoptolemos, J. P. ;
Ghaneh, P. .
BRITISH JOURNAL OF CANCER, 2008, 99 (01) :6-13